ACAD made a “strategic investment” in NEU as part of the July 2018 US licence agreement.
They acquired 1,330,000 share for A$4m, which was equivalent to ~ US$3m at the time.
The last sighting of ACAD’s investment in NEU was at 30/06/23. The reported value at that time was US$10,781,000.
From ACAD accounts, it appears that the company sold all of its holdings in NEU during Q3 last year.
NEU stock price at 30/06/23 was A$12.25. The price jumped to $14.20 by 21/07/23, following the signing of the global licence between Acadia and Neuren. The stock price then tracked down to A$10.47 on 22/09/23, a 26% decline over that two month period.
- Forums
- ASX - By Stock
- NEU
- Ann: Update - Notification of buy-back - NEU
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.62%
!
$17.67

Ann: Update - Notification of buy-back - NEU, page-15
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$17.67 |
Change
-0.110(0.62%) |
Mkt cap ! $2.230B |
Open | High | Low | Value | Volume |
$17.67 | $18.02 | $17.58 | $5.658M | 318.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 344 | $17.67 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.69 | 568 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 12169 | 17.580 |
8 | 1244 | 17.570 |
9 | 1041 | 17.560 |
12 | 6189 | 17.550 |
10 | 1128 | 17.540 |
Price($) | Vol. | No. |
---|---|---|
17.590 | 1694 | 9 |
17.600 | 1985 | 14 |
17.610 | 1903 | 13 |
17.620 | 2206 | 17 |
17.630 | 1844 | 13 |
Last trade - 14.42pm 11/08/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
WIN
WIN METALS LTD
Steve Norregard, CEO & MD
Steve Norregard
CEO & MD
SPONSORED BY The Market Online